Company / Free Cash Flow per Share
Oruka Therapeutics, Inc. Free Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.46
FY2024
5-year range
-$3.46 / -$0.35
FY2020-FY2024
Trend
-893.3%
vs FY2023
Sector context
#158 of 192
Health Care
What the data says
Free Cash Flow per Share changed -893% YoY in FY2024, a notable deviation from the 9-year average annual change of -147%.
Based on SEC 10-K filings.
-3.46 in FY2024.
Declined from $-1.30 to $-3.46 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 192This company -$3.46 Sector average $3.32
▼
-204.1% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share decreased 893.3% year-over-year.
- Ranks #158 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.46 | -893.3% |
| FY2023 | -$0.35 | +73.3% |
| FY2022 | -$1.30 | -60.9% |
| FY2021 | -$0.81 | +73.1% |
| FY2020 | -$3.01 | +71.7% |
| FY2019 | -$10.66 | -618.5% |
| FY2018 | -$1.48 | +10.1% |
| FY2017 | -$1.65 | -41.8% |
| FY2016 | -$1.17 | +62.7% |
| FY2015 | -$3.12 | -819.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026